Roquefort Therapeutics plc (ROQ.L) LSE

1.53

-0.1167(-7.07%)

Updated at August 19 08:11AM

Currency In GBp

Valuation

Market Cap9.36M
Enterprise Value8.83M
P/E Ratio-1.22
PEG Ratio-0.09
Price/Sales Ratio12.99
Price/Book Ratio0.39
Enterprise/Revenue10.3
Enterprise/EBITDA-1.07

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-8.72
Operating Margin-9.67

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.27

Income Statement

Revenue200,000
Revenue/Share0
Gross Profit200,000
EBITDA-1.93M
Net Income-1.74M
Diluted EPS-0.01

Balance Sheet

Total Cash595,662
Total Cash/Share0
Total Debt609,697
Total Debt/Equity0
Current Ratio2.26
Book Value Per Share0.04

Price History

52-Week Change-57.14
52-Week High6.78
52-Week Low1.08
Moving Average 50 Days1.56
Moving Average 200 Days2.45

Statistics

Average Volume1.23M
Shares Outstanding157.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A